|
|
 |
|
Viewing report
|
|
|
|
Erectile Dysfunction Drugs - Global Strategic Business Report
Global Industry Analysts, Inc., April 2010, Pages: 391
This report analyzes the worldwide markets for Erectile Dysfunction Drugs in US$ Million. The report provides separate comprehensive analytics for US, Canada, Japan, Europe,and Rest of the World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 26 companies including many key and niche players worldwide such as Abbott Laboratories, Eli Lilly and Company, Inc., F. Hoffmann-La Roche, Inc., GlaxoSmithKline plc, Nexmed, Inc., Pfizer, Inc., Sanofi-aventis SA, Vivus, Inc., and Warner Chilcott Limited. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Bipolar Disorder - Global Strategic Business Report
Antibacterial Drugs - Global Strategic Business Report
Drugstores - Global Strategic Business Report
Intravenous (IV) Iron Drugs - Global Strategic Business Report
Global Erectile Dysfunction Drug Pipeline Capsule - 2012
Anti-Infectives - Global Strategic Business Report
Anti-Hypertensive Drugs - Global Strategic Business Report
Bladder Cancer Therapeutics - Global Strategic Business Report
Anemia Drugs - Global Strategic Business Report
ADHD Therapeutics - Global Strategic Business Report
|
|
|
|
